We reviewed Staphylococcus aureus bloodstream infection isolates from SENTR
Y centers worldwide;during 1998 to evaluate the molecular epidemiology of m
ultiply drug-resistant methicillin (oxacillin)-resistant S, aureus (MDR-MRS
A), MDR-MRSA was defined as a S, aureus isolate with a MIC for oxacillin at
>2 mug/ml and with four or more additional resistances. A total of 325 uni
que patient isolates of MDR-MRSA from five continents were analyzed using r
ibotyping and pulsed-field gel electrophoresis (PFGE), The frequency of MDR
-MRSA among all S, aureus BSI isolates ranged from only 2.2% in Canada to 3
5.6% in the Asia-Pacific region. Forty-eight ribotypes (RT) were distinguis
hed, but over 80% of the isolates were contained within the 10 most prevale
nt RTs, The most common RT, RT 184.5, which included 30% of all MDR-MRSA, w
as found on four of five continents, PFGE provided superior discrimination
and identified numerous clusters of possible clonal dissemination of MDR-MR
SA within individual medical centers and between institutions that are in g
eographic proximity. In four instances,strains with indistinguishable PFGE
patterns were found on more than one continent. The predominant PFGE subtyp
e in South America (RT 893.5/Ia) was isolated from patients at centers in B
razil, Argentina, and Portugal, and closely related subtypes were:isolated-
in Chile and Italy. There is great geographic variation in rates of methici
llin and multidrug-resistance among S, aureus bloodstream isolates worldwid
e, Although many MDR-MRSA strains group geographically, a few closely relat
ed epidemic strains have wide regional and even global range.